{"id":"NCT00922233","sponsor":"FHI 360","briefTitle":"Pericoital Oral Contraception With Levonorgestrel","officialTitle":"Pericoital Oral Contraception With Levonorgestrel: A Prospective, Open-Label, Single Arm, Multicenter Study to Evaluate Efficacy, Safety and Acceptability","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-01","primaryCompletion":"2010-11","completion":"2010-11","firstPosted":"2009-06-17","resultsPosted":"2013-10-29","lastUpdate":"2013-10-29"},"enrollment":72,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Healthy"],"interventions":[{"type":"DRUG","name":"levonorgestrel","otherNames":[]}],"arms":[{"label":"Levonorgestrel","type":"EXPERIMENTAL"}],"summary":"A prospective, open-label, single arm, multicenter study to evaluate efficacy, safety and acceptability of pericoital oral contraception with levonorgestrel","primaryOutcome":{"measure":"Efficacy: the Pearl Index (Number of Pregnancies Per 100 Woman-years) in the Primary Evaluable Population (18-35)","timeFrame":"6.5 months","effectByArm":[{"arm":"Levonorgestrel","deltaMin":22.4,"sd":null}],"pValues":[]},"eligibility":{"minAge":null,"sex":"FEMALE","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":4,"countries":["United States","Brazil"]},"refs":{"pmids":["24388695"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":72},"commonTop":["anemia","vaginal candidiasis","headache","vaginal discharge","nausea"]}}